APWA
BIIB icon

Atlas Private Wealth Advisors’s Biogen BIIB Stock Holding History

Atlas Private Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-301
Closed -$85K – 211
2021
Q3 		$85K Hold
301
– – 0.04% 186
2021
Q2 		$104K Hold
301
– – 0.06% 154
2021
Q1 		$84K Buy
+301
New +$81.2K 0.05% 178

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Atlas Private Wealth Advisors's BIIB Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 301 shares — an estimated $85K sold.

Atlas Private Wealth Advisors first reported a position in BIIB in Q1 2021 and held it in 3 quarters. The position peaked at $104K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Atlas Private Wealth Advisors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 301 Biogen shares in Q4 2021, an estimated $85K.
  • Atlas Private Wealth Advisors first reported a position in Biogen in Q1 2021 and held it in 3 quarters.
  • Atlas Private Wealth Advisors's Biogen position peaked at $104K in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.